1. A biotech company ImmunX, has obtained blood samples from 2 groups of human volunteers (with their permission/consent of course). It appears that 10 of these people have melanoma and 10 do not. The
1. A biotech crew ImmunX, has obtained blood samples from 2 groups of civilized volunteers (after a while their permission/consent of route). It appears that 10 of these community possess melanoma and 10 do not. The 10 who are currently cancer patients possess a nativity narrative of cancer, inasmuch-as the other 10 healthful civilized volunteers possess no nativity narrative of any cancer. You are compensated by the crew to acceleration warrant the genes (in the healthful subjects) that may be under obligation for compensating the civilized volunteers from developing cancer and/or warranting the genes (in the cancer patients) that supply to the disorder. Explain what techniques you could use (and why) to acceleration warrant differentially developed genes in the two groups of community. Also, if you guess that mutations be in the DNA that are ancestral after a whilein the families that supply to disorder, what DNA sequencing techniques would you use (and why) to harangue this?